Haemodynamics in essential hypertension.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D001581:Benzothiadiazines; D004232:Diuretics; D006352:Heart Ventricles / Q000503:physiopathology; D006439:Hemodynamics; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology*; D008875:Middle Aged; D005082:Physical Exertion; D011311:Pressoreceptors / Q000503:physiopathology; D011652:Pulmonary Circulation; D012039:Regional Blood Flow; D012890:Sleep / Q000502:physiology; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D013315:Stress, Psychological / Q000503:physiopathology; D013564:Sympathetic Nervous System / Q000503:physiopathology
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors